Vendor source

Reviewed 11 May 2026

Completeness Strong (72%)

VUNO Med®-DeepBrain™

VUNO

It parcellates the brain into 100+ parts using 3D T1 non-contrast MRI and provides quantitative data describing volume, normative percentiles, and cortical thickness with color overlays. The solution assists the diagnosis of neurodegenerative disorders by analyzing the atrophy of main brain structures.

Supported by 2 papers

Key Features

  • Brain parcellation

General Information

Product name

VUNO Med®-DeepBrain™

Company

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Atrophy, Dementia

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

3D T1 Brain MRI

Input format

DICOM

Output

Parcellation of whole brain in 100 parts, Quantification of atrophy, Normal comparison

Output format

DICOM, NIFTI, PDF

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

10 - 60 seconds

Population

Population with a risk of brain atrophy

Market Presence

On market since

06-2020

AI Platforms

Resellers

Not specified

Countries present

10+

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Number of analyses

Source: Vendor | First published: Sep 4, 2024 | Last updated: May 11, 2026